Nerve Injury - Pipeline Review, H1 2015

Publisher Name :
Date: 22-Jan-2015
No. of pages: 61
Inquire Before Buying

Global Markets Direct's, ‘Nerve Injury - Pipeline Review, H1 2015', provides an overview of the Nerve Injury's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nerve Injury and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global therapeutic landscape of Nerve Injury

  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

  • The report reviews key players involved in the therapeutics development for Nerve Injury and enlists all their major and minor projects

  • The report summarizes all the dormant and discontinued pipeline projects

  • A review of the Nerve Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  • A detailed assessment of monotherapy and combination therapy pipeline projects

  • Coverage of the Nerve Injury pipeline on the basis of target, MoA, route of administration and molecule type

  • Latest news and deals relating related to pipeline products


Reasons to Buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

  • Develop strategic initiatives by understanding the focus areas of leading companies

  • Identify and understand important and diverse types of therapeutics under development for Nerve Injury

  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

  • Devise corrective measures for pipeline projects by understanding Nerve Injury pipeline depth and focus of Indication therapeutics

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Nerve Injury - Pipeline Review, H1 2015

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Nerve Injury Overview 7
Therapeutics Development 8
Pipeline Products for Nerve Injury - Overview 8
Pipeline Products for Nerve Injury - Comparative Analysis 9
Nerve Injury - Therapeutics under Development by Companies 10
Nerve Injury - Therapeutics under Investigation by Universities/Institutes 11
Nerve Injury - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Nerve Injury - Products under Development by Companies 14
Nerve Injury - Products under Investigation by Universities/Institutes 15
Nerve Injury - Companies Involved in Therapeutics Development 16
Acorda Therapeutics, Inc. 16
Calico LLC 17
Convergence Pharmaceuticals Ltd. 18
F. Hoffmann-La Roche Ltd. 19
Kolon Life Science, Inc. 20
Medtronic, Inc. 21
Neuralstem, Inc. 22
Neurotune AG 23
Pfizer Inc. 24
Nerve Injury - Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 34
3K3A-APC - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
cimaglermin alfa - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
CLP-257 - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
CNV-1014802 - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
KLS-Nst - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
MDT-15 - Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
NSI-566 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
NT-1654 - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Small Molecules to Activate NAMPT for Neurological Disorders - Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
Synthetic Peptides to Inhibit PDE-4A4 for Pulmonary Fibrosis and Nerve Injury - Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
WAY-258131 - Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Nerve Injury - Recent Pipeline Updates 49
Nerve Injury - Dormant Projects 58
Nerve Injury - Discontinued Products 59
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 61
Disclaimer 61

List of Tables

Number of Products under Development for Nerve Injury, H1 2015 8
Number of Products under Development for Nerve Injury - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Number of Products under Investigation by Universities/Institutes, H1 2015 11
Comparative Analysis by Clinical Stage Development, H1 2015 12
Comparative Analysis by Early Stage Development, H1 2015 13
Products under Development by Companies, H1 2015 14
Products under Investigation by Universities/Institutes, H1 2015 15
Nerve Injury - Pipeline by Acorda Therapeutics, Inc., H1 2015 16
Nerve Injury - Pipeline by Calico LLC, H1 2015 17
Nerve Injury - Pipeline by Convergence Pharmaceuticals Ltd., H1 2015 18
Nerve Injury - Pipeline by F. Hoffmann-La Roche Ltd., H1 2015 19
Nerve Injury - Pipeline by Kolon Life Science, Inc., H1 2015 20
Nerve Injury - Pipeline by Medtronic, Inc., H1 2015 21
Nerve Injury - Pipeline by Neuralstem, Inc., H1 2015 22
Nerve Injury - Pipeline by Neurotune AG, H1 2015 23
Nerve Injury - Pipeline by Pfizer Inc., H1 2015 24
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Stage and Target, H1 2015 27
Number of Products by Stage and Mechanism of Action, H1 2015 29
Number of Products by Stage and Route of Administration, H1 2015 31
Number of Products by Stage and Molecule Type, H1 2015 33
Nerve Injury Therapeutics - Recent Pipeline Updates, H1 2015 49
Nerve Injury - Dormant Projects, H1 2015 58
Nerve Injury - Discontinued Products, H1 2015 59

List of Figures

Number of Products under Development for Nerve Injury, H1 2015 8
Number of Products under Development for Nerve Injury - Comparative Analysis, H1 2015 9
Number of Products under Development by Companies, H1 2015 10
Comparative Analysis by Early Stage Products, H1 2015 13
Assessment by Monotherapy Products, H1 2015 25
Number of Products by Top 10 Targets, H1 2015 26
Number of Products by Stage and Top 10 Targets, H1 2015 26
Number of Products by Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 28
Number of Products by Top 10 Routes of Administration, H1 2015 30
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 30
Number of Products by Top 10 Molecule Types, H1 2015 32
Number of Products by Stage and Top 10 Molecule Types, H1 2015 32

  • Global Epilepsy Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 12-Oct-2018        Price: US 3480 Onwards        Pages: 147
    Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology. Scope of the Report: This report studies the Epilepsy Drugs market status and outlook of Global and major regions, from angles of players, count......
  • 2018-2023 Global Neuromyelitis Optica Drug Consumption Market Report
    Published: 11-Oct-2018        Price: US 6990 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Neuromyelitis Optica Drug market for 2018-2023. Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paraly......
  • Global Epilepsy Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Oct-2018        Price: US 3480 Onwards        Pages: 137
    Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure. Scope of the Report: This report focuses on the Epilepsy Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. It is one of the most common neurological disorders worldwide, affecting people of all a......
  • Global Ethoxyquin Market Insights, Forecast to 2025
    Published: 28-Sep-2018        Price: US 3900 Onwards        Pages: 112
    Ethoxyquin is a quinoline-based antioxidant used as a food preservative in certain countries and originally to control scald on pears after harvest (under commercial names such as "Stop-Scald"). In 2017, the global Ethoxyquin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Ethoxyquin market based on company, product type, application and key regions......
  • Global Antipsychotic Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 27-Sep-2018        Price: US 3480 Onwards        Pages: 118
    Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Scope of the Report: This report focuses on the Antipsychotic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes t......
  • Global Migraine Drugs Market Insights, Forecast to 2025
    Published: 19-Sep-2018        Price: US 3900 Onwards        Pages: 124
    This report studies the global market size of Migraine Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Migraine Drugs in these regions. This research report categorizes the global Migraine Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities a......
  • 2015-2023 World Edaravone Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 18-Sep-2018        Price: US 2800 Onwards        Pages: 84
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • Antipsychotic Drugs: Technologies and Global Markets
    Published: 18-Sep-2018        Price: US 5500 Onwards        Pages: 174
    Report Scope: This report provides a detailed description of the market for antipsychotic drugs. The report highlights the current and future market potential of antipsychotic drugs and provides a detailed analysis of the competitive environment, regulatory scenario, technological advancements, patent analysis, pipeline analysis, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2023, as well as market shares for key marke......
  • Global and Chinese Neuromyelitis Optica Drug Industry, 2018 Market Research Report
    Published: 13-Sep-2018        Price: US 3000 Onwards        Pages: 135
    The 'Global and Chinese Neuromyelitis Optica Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Neuromyelitis Optica Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Neuromyelitis Optica Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs